Wanyang Hengshui Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ANASTROZOLE, with a corresponding US DMF Number 40305.
Remarkably, this DMF maintains an Active status since its submission on December 19, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 19, 2025, and payment made on December 27, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II